Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia
Authors
Keywords
CD200, Acute myeloid leukemia, T-reg, Immunosuppression, Disease progression
Journal
TUMOR BIOLOGY
Volume 34, Issue 1, Pages 531-542
Publisher
Springer Nature
Online
2012-11-18
DOI
10.1007/s13277-012-0578-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blockade of CD200 in the Presence or Absence of Antibody Effector Function: Implications for Anti-CD200 Therapy
- (2014) A. Kretz-Rommel et al. JOURNAL OF IMMUNOLOGY
- CD200R signaling in tumor tolerance and inflammation: A tricky balance
- (2012) Tomasz P Rygiel et al. CURRENT OPINION IN IMMUNOLOGY
- Expression of CD200 on AML blasts directly suppresses memory T-cell function
- (2012) S J Coles et al. LEUKEMIA
- Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3+ regulatory T cells
- (2012) S J Coles et al. LEUKEMIA
- Synergistic effect of Toll-like receptor 4 and 7/8 agonists is necessary to generate potent blast-derived dendritic cells in Acute Myeloid Leukemia
- (2012) Maryam Nourizadeh et al. LEUKEMIA RESEARCH
- Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?
- (2011) C. Ustun et al. BLOOD
- Improving cancer immunotherapy by targeting tumor-induced immune suppression
- (2011) Trina J. Stewart et al. CANCER AND METASTASIS REVIEWS
- Foxp3high and Foxp3low Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood
- (2011) Sung Ki Lee et al. HUMAN IMMUNOLOGY
- Nature and nurture in Foxp3+ regulatory T cell development, stability, and function
- (2011) Terrence L. Geiger et al. HUMAN IMMUNOLOGY
- CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia
- (2011) S J Coles et al. LEUKEMIA
- Lymphatics: At the Interface of Immunity, Tolerance, and Tumor Metastasis
- (2011) JACQUELINE D. SHIELDS MICROCIRCULATION
- CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor
- (2011) T P Rygiel et al. ONCOGENE
- Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy
- (2010) Lixin Wang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells
- (2010) A. Curti et al. HAEMATOLOGICA
- Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cells
- (2010) Christopher Paustian et al. HUMAN IMMUNOLOGY
- Elevated frequencies of CD4+CD25+CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia
- (2010) Zhang Shenghui et al. INTERNATIONAL JOURNAL OF CANCER
- CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation
- (2010) S. Maury et al. Science Translational Medicine
- Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease
- (2009) Kaori Sato et al. BLOOD
- Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
- (2009) Q. Zhou et al. BLOOD
- Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response
- (2009) Stéphanie Delluc et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia
- (2009) M. J. Szczepanski et al. CLINICAL CANCER RESEARCH
- High Erk-1 activation and Gadd45a expression as prognostic markers in high risk pediatric haemolymphoproliferative diseases
- (2009) Velia D'Angelo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function
- (2009) Maciej Kmieciak et al. Journal of Translational Medicine
- Increased Interleukin-10 Production Without Expansion of CD4+CD25+ T-Regulatory Cells in Early Stable Renal Transplant Patients on Calcineurin Inhibitors
- (2009) Sharad K. Mittal et al. TRANSPLANTATION
- Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia
- (2008) Tohid Kazemi et al. INTERNATIONAL JOURNAL OF CANCER
- Back to basics: In search of the optimal dendritic cell for vaccination in AML
- (2008) Willemijn van den Ancker et al. LEUKEMIA RESEARCH
- Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade
- (2008) Christian P. Pallasch et al. LEUKEMIA RESEARCH
- CD200: A putative therapeutic target in cancer
- (2007) Jérôme Moreaux et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More